KELSEA KILL: Open Payments
NPI 1508624065 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 111 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $1,667 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $332 |
| Novo Nordisk Inc | 11 | $168 |
| Lilly USA, LLC | 13 | $165 |
| GlaxoSmithKline, LLC. | 9 | $160 |
| PFIZER INC. | 5 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $113 |
| Astellas Pharma US Inc | 3 | $71 |
| ABIOMED | 3 | $52 |
| Radius Health, Inc. | 2 | $46 |
| Dexcom, Inc. | 2 | $42 |
Products named: TRELEGY ELLIPTA, QULIPTA, Kerendia, MOUNJARO, NURTEC ODT, VRAYLAR, Ozempic, Wegovy.
Industry payments across TX — which companies pay providers there.
